EUVIMEDEUVIMED entdecken
Crossref

Experts’ position paper on the diagnostics of the PI3K–AKT–mTOR signaling pathway in hormone-dependent breast cancer

Barbara Radecka, Małgorzata Stawicka-Niełacna, Małgorzata Oczko-Wojciechowska, Artur Kowalik, Katarzyna Pogoda, Joanna Kufel-Grabowska, Andrzej Tysarowski

Oncology in Clinical Practice · 15.01.2026 · 22

DOI: 10.5603/ocp.111111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology in Clinical Practice, online erschienen am 15.01.2026. Verfasst von Barbara Radecka und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Radecka, B., Stawicka-Niełacna, M., Oczko-Wojciechowska, M., Kowalik, A., Pogoda, K., Kufel-Grabowska, J., & Tysarowski, A. (2026). Experts’ position paper on the diagnostics of the PI3K–AKT–mTOR signaling pathway in hormone-dependent breast cancer. Oncology in Clinical Practice, 22(0). https://doi.org/10.5603/ocp.111111

Vancouver

Radecka B, Stawicka-Niełacna M, Oczko-Wojciechowska M, Kowalik A, Pogoda K, Kufel-Grabowska J, et al. Experts’ position paper on the diagnostics of the PI3K–AKT–mTOR signaling pathway in hormone-dependent breast cancer. Oncology in Clinical Practice. 2026;22(0). doi:10.5603/ocp.111111

BibTeX
@article{Radecka2026,
  author = {Radecka, Barbara and Stawicka-Niełacna, Małgorzata and Oczko-Wojciechowska, Małgorzata and Kowalik, Artur and Pogoda, Katarzyna and Kufel-Grabowska, Joanna and Tysarowski, Andrzej},
  title = {Experts’ position paper on the diagnostics of the PI3K–AKT–mTOR signaling pathway in hormone-dependent breast cancer},
  journal = {Oncology in Clinical Practice},
  year = {2026},
  volume = {22},
  number = {0},
  doi = {10.5603/ocp.111111}
}
Kostenlos starten →